Caroline Even

5PUBLICATIONS
79CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
HPV16 genomic status stratifies risk of disease recurrence in oropharyngeal squamous cell carcinoma.

|Mar 23, 2026
Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project.

Athénaïs van der Elst, Daniel Herrero-Saboya, Lucas Michon

|Feb 10, 2026
Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti-PD-1 Treatment.

Athénaïs van der Elst, Daniel Herrero-Saboya, Lucas Michon

|Jan 20, 2025
First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr-Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies.

A Dimitrios Colevas, Zahra Talebi, Elizabeth Winters

|Dec 12, 2024
Sacituzumab Govitecan in Patients with Relapsed/Refractory Advanced Head and Neck Squamous Cell Carcinoma: Results from the Phase II TROPiCS-03 Basket Study.

Loren Michel, Antonio Jimeno, Ammar Sukari

Pageof 1

Frequent Collaborators

2 joint publications

Marie Morfouace

2 joint publications

Nils Eling

2 joint publications

Daniel Schulz

2 joint publications

Robin Liechti